Moderna (MRNA) has had the worst year this year by a US stock in the S&P 500 (GSPC) this year, returning -59.2%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Moderna (MRNA) | 2024 | -59.19% |
Walgreens Boots Alliance (WBA) | 2024 | -58.62% |
Intel (INTC) | 2024 | -57.9% |
Celanese (CE) | 2024 | -54.57% |
Dollar Tree (DLTR) | 2024 | -50.71% |
Humana (HUM) | 2024 | -48.73% |
Estee Lauder Companies (EL) | 2024 | -44.63% |
Enphase Energy (ENPH) | 2024 | -43.82% |
Dollar General (DG) | 2024 | -43.33% |
CVS Health (CVS) | 2024 | -41.85% |
Biogen (BIIB) | 2024 | -41.51% |
APA (APA) | 2024 | -39.75% |
DexCom (DXCM) | 2024 | -36.83% |
Qorvo (QRVO) | 2024 | -36.21% |
Aptiv (APTV) | 2024 | -35.07% |
Microchip Technology (MCHP) | 2024 | -33.12% |
Amentum (AMTM) | 2024 | -32.78% |
Boeing (BA) | 2024 | -32.75% |
Albemarle (ALB) | 2024 | -30.72% |
AES (AES) | 2024 | -30% |
Nucor (NUE) | 2024 | -29.66% |
Teleflex (TFX) | 2024 | -27.43% |
Devon Energy (DVN) | 2024 | -27.01% |
Mosaic (MOS) | 2024 | -26.5% |
Nike (NKE) | 2024 | -26.26% |
